Investment Team

Health & Bio

Computing, AI, and biology are advancing at breakneck speed, propelling a new wave of category-defining healthcare and life sciences companies, with Europe at the forefront. 

We are the first backers of ambitious, impatient, and relentless founders who fuse world-class AI/ML and product expertise with deep healthcare workflow, regulatory, and incentive knowledge.

If you’re building solutions that radically improve outcomes, access, or cost of care; unlock a new era of tech-enabled healthcare and life sciences services; power a secure, connected, AI ecosystem; transform discovery, delivery, or manufacturing of new therapies; or reinvent clinical trial simulation and execution – let’s talk.

Health & Bio Team
Andrea Zitna

Andrea Zitna

Partner
Daria Gherghelas

Daria Gherghelas

Investor
Estelle Botbol

Estelle Botbol

Principal
Health Advisory Circle
Alumni

Dr. Sven Jungmann

Healthtech Founder, MD
Alumni

Dr. Yacine Hadjiat

Innovation, Dubai Health
Alumni

Nathan Hubbard

CEO, Flatiron Health
Alumni

Prathib Skandakumaran

Sr. Director of Corp Dev, Mayo Clinic
Alumni

Dr. Anne Phelan

VP, Pfizer
Alumni

Dr. Namshik Han

Head of AI & Biology, Cambridge
Alumni

Dr. Penny Dash

Chair, NHS UK
Alumni

Keith Gibbs

Former CEO, AXA Healthcare
Health & Bio Portfolio
hi.health

Convenient and safe access to private health insurance billing.

Sector
Health & Bio
Exits
AI & Infra
Year Invested
2019
IOMED

Better ICD-10 coding and big data insights for hospitals.

Sector
Health & Bio
AI & Infra
Year Invested
2018
Juli

Improving life for people with chronic conditions.

Sector
Health & Bio
Year Invested
2022
MiLaboratories

The leader in immunome data analysis software with flagship product MiXCR.

Sector
Deep Tech
Health & Bio
Year Invested
2022
Molecule

Connecting life science research to funding.

Sector
Health & Bio
Year Invested
2022
Mpiriq

MPIRIQ links everyday clinical data with medical research to turn routine patient care into insights that accelerate new therapies.

Sector
Health & Bio
Year Invested
2024
NeuroHarmonics

Building the future of non-invasive neuromodulation using focused ultrasound to modulate deep brain circuits safely.

Sector
Health & Bio
Year Invested
2025
Nilo Health

The mental well-being support for your entire workforce.

Sector
Health & Bio
Marketplaces & Consumer
Year Invested
2022
Health & Bio Articles
TechBio x AI Drug Discovery: From Concept to Reality
Read
Morning Coffee with Fanny Jaulin, founder of Orakl Oncology
Read
Morning Coffee with Bradley Treeby, Co-Founder and CEO of NeuroHarmonics
Read
Longevity & Healthy Ageing Report: How Tech is Helping us Live Longer and Healthier Lives
Read